HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide
0.1.0 - CI Build

HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide, published by Te Aho o Te Kahu, Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7NZ/cca/ and changes regularly. See the Directory of published versions

Artifacts Summary

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

Behavior: Capability Statements

The following artifacts define the specific capabilities that different types of systems are expected to have in order to comply with this implementation guide. Systems conforming to this implementation guide are expected to declare conformance to one or more of the following capability statements.

CapabilityStatement

Represents API exposed to retrieve plans

Structures: Logical Models

These define data models that represent the domain covered by this implementation guide in more business-friendly terms than the underlying FHIR resources.

CancerRegimensLM

CancerRegimens

Structures: Resource Profiles

These define constraints on FHIR resources for systems conforming to this implementation guide.

ActivityDefinition

CCA Regimen Activity Definition.

PlanDefinition

CCA Regimen Plan Definition.

Structures: Data Type Profiles

These define constraints on FHIR data types for systems conforming to this implementation guide.

Dosage

CCA Regimen Dosage.

Structures: Extension Definitions

These define constraints on FHIR data types for systems conforming to this implementation guide.

AdditionalDetails

Allows additional information to be added to a regimen such as dosing modification details

Disclaimer

A disclaimer for use of this Plan

Instructions for use

Specific instructions for use of the regimen overall, or for the individual cycles

LocationAdministration

The physical Location where the medication administration occurs (eg home or clinic)

LocationMedicationCollection

The physical Location where the medication can be collection prior to collection

Off label

Indicates that the medication is being used for a purpose for which it has not been specifically approved

Regimen type

The overall type of the regimen - eg FOLFOX

Regimen under review

Additional status values for PlanDefinition. Currently only a single value - review - indicating that a regimen is published and available to be used, but there is still a review being performed, so could change. In most situations the value of the status element itself will be ‘active’

Replaced by

When a Plan has been deprecated (superceeded or discontinued), refers to the one that replaces it, if any

SupportFactor

Support factors needed during treatment

TimingOfDays

Allows specific days to be indicated in a component of a regimen cycle. extends the idea of UV extension: http://hl7.org/fhir/extension-timing-daysofcycle.html by adding instructions

TreatmentSetting

The setting of the regimen - what is its purpose

Terminology: Value Sets

These define sets of codes used by systems conforming to this implementation guide.

Administration location

The physical location where the administration occurred - eg at home or in a clinic

Cancer type

The type of Cancer

Medication collection location

The physical location where the medication can be collected on prior to administration - eg a pharmacy

Medication dose administration frequency

The dose administration frequency

Medication dose unit

The dose unit

PlanDefinition additional status

Other codes used for the PlanDefinition status

Possible values for Support Factors

The set of all possible support factors values (not specific to any one factor)

Regimen type code

The type of regimen - eg FOLFOX

Route

Route

Support Factors

The set of possible support factors (not their values)

Treatment setting

The setting of the regimen - what is its purpose

Terminology: Code Systems

These define new code systems used by systems conforming to this implementation guide.

PlanDefinition additional status

Other codes used for the PlanDefinition status

Regimen type code

Codes used for the regimen type

Treatment setting

The setting of the regimen - what is its purpose

Example: Example Instances

These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.

ActCabergoline

Cabergoline Administration

ActTragacanth

Tragacanth Administration

Colorectal Adjuvant FOLFOX (a7)

Example Plan definition for coloRectal cancer

GU PROS Castration resistant Metastatic - abiraterone and dexamethasone

A drug treatment regimen for Urogenital Prostate Castration resistant Metastatic - abiraterone and dexamethasone

GYN END Adjuvant - cISplatin chemoradiation followed by cARBOplatin and PACLItaxel

A drug treatment regimen for Gynaecological Endometrial Adjuvant - cISplatin chemoradiation followed by cARBOplatin and PACLItaxel

LUNG NSCLC Metastatic - alectinib

A drug treatment regimen for Respiratory Non small cell lung cancer Metastatic - alectinib

LUNG NSCLC NON-Metastatic - alectinib

A drug treatment regimen for Respiratory Non small cell lung cancer NON-Metastatic - alectinib

SuperceededPlan

A plan that has been superceeded by another